Health care workers and nursing home residents should be at the front of the line when the first coronavirus vaccine shots become available, an influential government advisory panel said Tuesday.
Drugmakers Pfizer and BioNTech said Wednesday they've won permission for emergency use of their COVID-19 vaccine in Britain, the world’s first coronavirus shot that’s backed by rigorous science - and a major step toward eventually ending the pandemic.
From a production facility in Belgium to a storage facility in Michigan, drugmaker Pfizer is preparing to distribute its COVID-19 vaccine as soon as it gets the go-ahead. This news comes as Moderna says it's also seeking emergency authorization for its vaccine.
The nation's top doctors are warning of a post-holiday spike in coronavirus cases. That's on top of the surge in infections and hospitalizations we're seeing nationwide as winter approaches.
Los Angeles County issued a new stay-home order that begins on Nov. 30 and will remain in effect until Dec. 20.
A vaccine for COVID-19 will begin to be available in the U.S. “probably by the end of the second week in December,” according to Dr. Robert Redfield, director of the Centers for Disease Control and Prevention.
Scientists have been working tirelessly for a breakthrough to fight the coronavirus.
U.S. health officials Saturday agreed to allow emergency use of a second antibody drug to help the immune system fight COVID-19, an experimental medicine that President Donald Trump was given when he was sickened last month.
Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic.
The pharmaceutical giant Pfizer announced Wednesday it will seek regulatory approval for its COVID-19 vaccine “within days.”